&w=3840&q=100)
Sun Pharma, Lupin, Dr Reddy's recall products in US due to mfg issues
As per the latest Enforcement Report of US Food and Drug Administration (USFDA), the Mumbai-headquartered Sun Pharmaceutical Industries is recalling 5,448 bottles of a generic medication in the US.
Princeton-based Sun Pharmaceutical Industries Inc is recalling the affected lot of Lisdexamfetamine Dimesylate capsules (60 mg) due to "Failed Dissolution Specifications", the US health regulator stated.
The medication is used to treat attention deficit hyperactivity disorder (ADHD).
The drug firm initiated the Class II recall in the US on June 16 this year, it added.
Another Mumbai-based drug maker Lupin is recalling 58,968 bottles of a generic combination medication used to treat high blood pressure.
Naples-based Lupin Pharmaceuticals Inc is recalling Lisinopril and Hydrochlorothiazide tablets (USP 20mg/12.5mg). The affected lot was manufactured at the company's Nagpur-based manufacturing facility.
As per the USFDA, the company initiated the Class II recall on June 20 due to "Product Mix Up".
This product is being recalled because of a complaint received that a sealed bottle of lisinopril and hydrochlorothiazide tablets 20mg/12.5 mg had a foreign tablet identified as atazanavir and ritonavir tablet 300mg/100mg, the US health regulator stated.
In another filing, the US health regulator said that Dr Reddy's Laboratories is recalling 1,476 bottles of Omeprazole Delayed-release capsules.
The medication is used to treat certain stomach and esophagus problems.
Princeton-based Dr. Reddy's Laboratories, Inc initiated the Class II recall on June 30, 2025, USFDA stated.
The affected lot was produced at the company's Bachupally (Telangana)-based manufacturing facility.
The recall is due to the presence of foreign tablets/capsules, USFDA said.
It is due to the presence of foreign Divalproex Sodium extended-release 250mg tablets in a bottle of omeprazole capsules, it added.
As per the USFDA, a Class-II recall is initiated when the use of, or exposure to, a violative product may lead to temporary or medically reversible health consequences, or when the likelihood of serious adverse health outcomes is minimal.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
3 hours ago
- Time of India
PE funds vie for a majority stake in medical devices maker Sensa Core
Mumbai: KKR , TPG, Kedaara Capital , and Multiples Alternate Asset Management are among homegrown and global private equity firms in early-stage discussions to acquire a majority stake in Sensa Core Medical Instrumentation , one of India's leading medical device manufacturers, said people familiar with the matter. A potential deal is likely to value the Hyderabad-based company at about $300 million (about ₹2,600 crore), the people said. They added that the interested PE firms are likely to submit non-binding bids within the next month. Explore courses from Top Institutes in Please select course: Select a Course Category Digital Marketing Technology Healthcare Degree Design Thinking Leadership Finance Product Management Operations Management PGDM Data Science Public Policy Data Science CXO Project Management Cybersecurity others MCA Artificial Intelligence healthcare Management Others Data Analytics MBA Skills you'll gain: Digital Marketing Strategies Customer Journey Mapping Paid Advertising Campaign Management Emerging Technologies in Digital Marketing Duration: 12 Weeks Indian School of Business Digital Marketing and Analytics Starts on May 14, 2024 Get Details Skills you'll gain: Digital Marketing Strategy Search Engine Optimization (SEO) & Content Marketing Social Media Marketing & Advertising Data Analytics & Measurement Duration: 24 Weeks Indian School of Business Professional Certificate Programme in Digital Marketing Starts on Jun 26, 2024 Get Details The people cited above did not disclose the size of the stake the PE firms are looking to acquire. Owned by the Meruva family, Sensa Core is one of the largest domestic producers of in-vitro diagnostic analysers and point-of-care devices. Its key products include blood gas analysers, electrolyte analysers, glucose meters, lactate meters, haemoglobin meters, and cholesterol meters. Investment bank Veda Corporate Advisors is advising the promoters of Sensa Core on the potential transaction. Live Events "The said information is baseless, and we do not respond to rumours," said Nagaraju Meruva, executive director at Sensa Core Medical Instrumentation. A KKR spokesperson declined to comment. Mails sent to TPG, Kedaara, Multiples did not elicit any response. Founded in 2006 by Ravi K. Meruva, Sensa Core also provides operational support and maintenance services for other electrolyte analyser brands. In FY25, Sensa Core is estimated to have recorded a revenue of about ₹400 crore, and ₹80-100 crore in EBITDA, people said. "Medical devices are one of the most attractive sectors for private equity investors," said a PE fund manager evaluating a potential bid for Sensa Core. "Once a strong distribution network is in place and trust is established with doctors, companies in this space tend to generate steady, predictable revenues. Today, Indian medical device manufacturers are on par with global players in terms of quality." India's medtech space is experiencing a surge in investor interest. Last week, UAE sovereign wealth fund Abu Dhabi Investment Authority (ADIA) took a minority stake in Micro Life Sciences (Meril), a Warburg Pincus-backed firm, for $200 million. Global investor KKR, which has been actively investing in the healthcare sector, acquired Healthium Medtech (formerly Sutures India) from Apax Partners in a deal valued at ₹7,000 crore last year. Prior to Apax, TPG Growth held a 75% stake in Healthium. Last year, PE contenders KKR, TPG Capital , and Apax had shown initial interest in acquiring Sahajanand Medical Technologies (SMT), India's largest manufacturer of cardiac stents. However, the deal didn't materialise and SMT is currently preparing for an IPO. SMT counts Morgan Stanley PE Asia and Samara Capital among its investors, with the two collectively holding a 49% stake. India's medical devices industry, valued at $12 billion as of FY24, is projected to grow more than fourfold to $50 billion by 2030. Over the next 25 years, India's global market share in this industry is projected to climb to 10-12% from 1.6% currently. Indian medtech exports reached $3.8 billion in FY24, with the US as the primary market. Despite robust exports, India remains heavily import-reliant, with $8.2 billion in imports, and as much as 80-85% of medical devices sourced internationally, according to a recent EY report. With strategic growth and innovation, India is well-positioned to strengthen its medtech industry and reduce import dependency, making significant strides toward becoming a global leader in the sector, the report said.
New Indian Express
7 hours ago
- New Indian Express
Spellbinding stripes
Surgeon with tiger tattoos It was the call of the tigers that made Dr Krishnakumar Mechoor, an orthopaedic surgeon, fall in love with the wild. His fascination with the enigmatic cat began after watching Nat Geo documentaries. 'And I bought my first camera just to photograph tigers,' he says. It was after completing his studies and starting work that Krishnakumar first ventured into Bandipur to see a tiger for real. 'They are really shy, solitary beings. That's why spotting a tiger in the wild — even from a distance — gives such a high,' says Dr Krishnakumar. 'Tiger is the apex predator. The entire forest comes alive when a tiger is on the prowl. Birds and monkeys start warning calls, other animals flee as soon as possible. Even the trees and wind seem to react.' Photographs are secondary to him, says the Thrissur-based doctor. 'It's that moment of seeing a tiger with bare eyes that gives me a kick,' he adds. Dr Krishnakumar recalls seeing a tigress, Maya, the dominant female from Tadoba Tiger Reserve. 'She was training her cubs. I got to just sit and watch her cubs hunt a piglet. I will never forget that moment,' he says. Jim Corbett remains his favourite wildlife sanctuary. 'You can see tigers crossing the Ram Ganga River. In winter, they grow a fur coat, which makes them appear even larger. It's where Parwali and Pedwali rule,' he smiles. Interestingly, the surgeon has tattoos of Parwali and her paw print on his arm. Their lives are very difficult, he says. 'Territorial wars and attacks from other tigers make it hard for them to nurture their cubs,' he says. According to him, Parwali has had four litters, but only one cub, Pedwali, has made it to adulthood. 'Only by watching them can you understand the challenges they face. Tourism both helps and harms. While it promotes tiger conservation, it also disturbs their natural habitat, especially during hunting,' says Dr Krishnakumar. That's one reason why Kerala isn't ideal for tiger sightings. 'Only 15 percent of our forests are open to the public. Tigers rarely appear there. Otherwise, you must travel with researchers,' he says Dr Krishnakumar says Wayanad, like Bandipur and Kabini, should have been a tiger reserve. 'The lack of it is why we see so many conflicts. A good chunk of forest has been encroached upon by humans,' he laments.
India Today
9 hours ago
- India Today
How makeup on babies can trigger allergies and disrupt hormones
Dabbing perfume on a baby, painting their tiny nails with polish containing formaldehyde or dusting blush onto their cheeks for a photoshoot, might sound like innocent acts in the age of social media, but such practices are actually far from kajal applied to eyelids to mehendi drawn on tiny hands, cosmetic use on babies and toddlers is increasingly common. In fact, you type 'child makeup influencers' and you're bound to get dozens of Instagram Reels showcasing young girls doing the multi-step skincare routine or picking up a large eyeshadow kit and applying loads of glitter dust on their eyelids and does science say when it comes to applying cosmetic products? Infant skin is fundamentally different from adult skin, it's thinner, more permeable, and still in development. This makes it more susceptible to irritation, allergic reactions, and long-term health risks, including hormonal disruption. Newborns have the same number of skin layers as adults, but those layers are up to 30% thinner. This means chemicals from cosmetics can more easily pass through the skin and into deeper tissues or the to Adam Taylor, an expert in anatomy at Lancaster University, baby skin also contains more water and less sebum, the natural oil that acts as a protective barrier. This increases vulnerability to dryness and irritation, especially when exposed to products not specifically designed for infant skin, he wrote in The Conversation Delhi-based dermatologist Dr. Deepali Bhardwaj cautioned, 'You cannot use kajal, it needs to be very genuine and authentic. Many over-the-counter products may contain harmful additives or chemicals not suitable for a baby's delicate eyes and skin," advising against casual use of traditional or cosmetic formulations on skincare ingredients are likely to harm health by disrupting hormones or causing allergies. Alkylphenols, triclosan, and BPA can affect hormone activity, while cyclosiloxanes may build up in the body. Ethanolamines can form potentially harmful compounds, and parabens mimic estrogen. Phthalates are linked to reproductive issues, especially in children, and benzophenone in sunscreens may trigger allergic reactions and hormonal to the issue is the increasing presence of children's makeup and body products in the market. These include everything from body glitter and face paint to lipstick, nail polish, hair gel, and perfume.A 2023 study published in Environmental Research and Public Health by Columbia University researchers highlights this growing trend and the accompanying risks. These items are often designed with bright colours and cartoon characters to appeal to children, and marketed through social media platforms that even young users can contain multiple allergens, including fragrance compounds, lanolin (wool alcohol), preservatives, and hair dye chemicals. Even products labelled 'natural' or 'herbal' are not automatically safe. In fact, allergic contact dermatitis is a well-documented reaction to many of these researchers found that most children in the US use makeup and body products that may contain carcinogenic and other toxic chemicals. Many cosmetic products for children contain heavy metals and other toxic chemicals that are linked to cancer, neurodevelopmental harm, and other serious and irreversible health bottom line is that the skin of infants and toddlers is not equipped to handle cosmetic products meant for adults—or even for older children. As the wellness industry continues to push boundaries, experts urge parents to prioritise safety and long-term health over short-term aesthetics or trends.- Ends
